one
danger
human
pathogen
high
preval
worldwid
streptococcu
pyogen
major
impact
global
morbid
mortal
major
challeng
pyogen
vaccin
develop
detect
epitop
confer
protect
infect
multipl
pyogen
type
aim
identifi
conserv
immunogen
antigen
pyogen
potenti
candid
vaccin
design
futur
eight
import
surfac
protein
analyz
use
differ
predict
server
strongest
epitop
select
abil
stimul
humor
cellmedi
immun
system
molecular
dock
perform
measur
freebind
energi
select
epitop
seven
epitop
three
surfac
protein
select
potenti
candid
vaccin
develop
conserv
select
epitop
among
differ
streptococcu
type
check
vitro
vivo
test
requir
valid
suitabl
epitop
vaccin
design
group
streptococci
streptococcu
pyogen
betahemolyt
gramposit
bacteria
nonmotil
facult
anaerob
ferment
grow
short
chain
pair
serotyp
group
streptococci
report
year
rebecca
lansfield
introduc
method
classif
base
specif
group
carbohydr
cell
wall
pyogen
human
pathogen
colon
skin
throat
result
diseas
vari
present
clinic
sever
pyogen
infect
respons
rheumat
heart
diseas
rhd
bacteri
pharyng
poststreptococc
rheumat
fever
rf
cellul
rheumat
heart
diseas
rhd
glomerulonephr
psgn
pyogen
also
caus
agent
sever
invas
diseas
includ
toxic
shock
syndrom
necrot
fasciiti
diseas
associ
pyogen
estim
kill
half
million
peopl
year
annual
global
burden
ga
diseas
estim
million
case
pyoderma
least
death
due
sever
invas
diseas
sequela
million
case
pharyng
report
show
major
ga
impact
global
morbid
mortal
major
death
occur
develop
nation
attribut
rhd
autoimmun
consequ
pyogen
infect
immun
cell
molecul
combat
epitop
bacteri
protein
attack
host
protein
tissu
effect
option
treatment
primari
step
rhd
antibiot
treatment
ideal
approach
prevent
rhd
pyogen
infect
prevent
vaccin
obviou
primari
step
infect
firm
intim
specif
adher
bacteria
host
cell
tissu
utmost
import
bacteri
surfac
protein
involv
interact
host
cell
henc
surfac
protein
good
potenti
target
effect
vaccin
aim
prevent
bacteri
diseas
infect
investig
show
mani
bacteri
speci
surfac
protein
success
impli
immunotherapeut
approach
develop
vaccin
tradit
method
though
success
time
complex
process
involv
cultur
live
organ
inactiv
reinject
subject
check
immun
respons
isol
antigen
specif
organ
henc
process
costli
time
consum
low
success
rate
difficult
organ
cultur
vitro
epitopedriven
vaccin
attract
concept
success
pursu
larg
number
research
group
especi
design
vaccin
target
conserv
epitop
rapidli
mutat
pathogen
studi
show
use
epitop
predict
method
combin
molecular
dock
techniqu
improv
predict
accuraci
significantli
molecular
dock
appli
order
measur
freebind
energi
select
epitop
freebind
energi
depend
conform
protein
ligand
bind
specif
cellular
immun
respons
base
recognit
cytotox
lymphocyt
immunogen
peptid
present
context
class
major
histocompat
complex
mhc
due
import
central
role
lymphocyt
immun
respons
molecular
basi
interact
peptidemhc
pmhc
complex
cell
receptor
tcr
gener
interest
medicin
immunolog
well
understand
factor
contribut
stabil
specif
format
proteinprotein
proteinpeptid
complex
select
epitop
vaccin
conserv
across
differ
stage
pathogen
furthermor
desir
immun
respons
taken
consider
almost
imposs
identifi
develop
univers
vaccin
candid
use
convent
method
variabl
organ
like
pyogen
variou
strain
studi
present
revers
vaccinolog
method
predict
epitop
epitop
predict
strategi
present
base
identif
antigen
epitop
select
abl
simul
humor
cellmedi
immun
molecular
techniqu
use
order
model
interact
select
epitop
mhc
allel
tcr
allow
identifi
peptid
result
neg
freebind
energi
peptidemhctcr
bind
final
conserv
peptid
among
differ
pyogen
type
check
sequenc
eight
differ
surfac
protein
pyogen
high
degre
conserv
ncbi
protein
databas
select
surfac
protein
access
number
shown
tabl
order
find
protein
antigen
whole
protein
sequenc
test
vaxijen
wwwddgpharmfacnetvaxijen
allow
antigen
classif
sole
base
physicochem
properti
protein
without
recours
sequenc
align
tmhmm
server
wwwcbsdtudk
use
topolog
predict
server
confirm
surfac
exposur
find
cell
epitop
part
b
cell
epitop
help
evok
immun
system
power
way
first
step
epitop
design
linear
nonoverlap
b
cell
epitop
predict
done
abcpr
freeli
avail
www
imtechresinraghavaabcpr
epitop
score
accept
check
antigen
exomembran
locat
use
vaxijen
tmhmm
server
use
mhc
class
epitop
predict
server
identifi
allel
propr
server
use
predict
mhc
classii
allel
bind
site
server
use
tool
locat
promiscu
bind
region
bind
sever
hla
allel
promiscu
cell
epitop
could
bind
differ
mhc
class
ii
allel
due
signific
polymorph
peptid
bind
groov
mhc
molecul
import
determin
promiscu
epitop
studi
epitop
bind
least
seven
mhc
allel
class
ii
select
also
mhcpred
use
predict
epitop
mhcpred
use
partial
least
squar
base
approach
predict
bind
affin
mhc
molecul
mhcpred
use
crosscheck
ensur
select
epitop
two
previou
server
server
correctli
predict
vaxijen
server
use
analyz
select
epitop
antigen
number
frequent
mhc
allel
human
popul
mhcpred
use
predict
bind
affin
mention
allel
select
epitop
result
given
term
inhibitori
concentr
epitop
valu
less
nm
least
three
allel
select
order
analyz
molecular
dock
structur
select
peptid
allel
tcr
need
structur
allel
tcr
retriev
protein
data
bank
wwwrcsborgpdbhomehomedo
pdb
id
pdb
id
pdb
id
pdb
id
tcr
pdb
id
extra
atom
water
molecul
omit
pdb
file
tertiari
structur
select
peptid
predict
use
pepstr
server
predict
structur
peptid
sequenc
given
input
cluspro
server
wide
use
tool
proteinprotein
dock
firstli
dock
peptid
mhc
molecul
use
cluspro
central
residu
peptid
expos
mhc
complex
recogn
tcr
therefor
subsequ
mhcpeptid
complex
dock
onto
tcr
molecul
use
cluspro
section
select
conform
minimum
freebind
energi
score
last
step
select
cell
epitop
sequenc
analyz
see
conserv
among
differ
streptococcu
type
conserv
check
protein
blast
antigen
analysi
fulllength
protein
show
antigen
rang
capsul
synthesi
protein
protein
tmhmm
softwar
exhibit
protein
exomembran
locat
therefor
protein
suitabl
epitop
predict
b
cell
epitop
surfac
protein
identifi
use
abcpr
twentym
nonoverlap
b
cell
epitop
score
select
select
epitop
analyz
antigen
exomembran
topolog
use
vaxijen
tmhmm
number
detect
accept
epitop
shown
tabl
b
cell
epitop
surfac
protein
analyz
detect
promiscu
cell
epitop
within
b
cell
epitop
propr
propr
use
detect
promiscu
cell
epitop
share
sequenc
select
b
cell
epitop
result
epitop
predict
mhcpred
server
select
epitop
two
previou
server
prope
propr
predict
epitop
mhcpred
result
sever
confirm
previou
result
subsequ
promiscu
cell
epitop
analyz
antigen
use
vaxijen
protein
promiscu
epitop
abl
bind
least
seven
allel
seven
protein
promiscu
allel
fulfil
mention
criteria
identifi
epitop
list
tabl
investig
common
mhc
ii
allel
human
popul
bind
affin
peptid
mention
allel
measur
mhcpred
step
screen
search
peptid
abil
bind
least
allel
nm
capsul
synthesi
lamininbind
surfac
protein
lmb
lipoteicho
acid
synthas
lta
type
iic
strypsinresist
surfac
protein
promiscu
cell
epitop
bind
least
mention
allel
nm
tabl
show
epitop
fulfil
mention
criteria
molecular
dock
final
peptid
done
candid
mhc
ii
allel
subsequ
peptidemhc
complex
dock
onto
tcr
molecul
use
clusprp
peptid
low
freebind
energi
dock
mhc
ii
allel
tcr
mean
select
epitop
good
vaccin
candid
epitop
peptidas
protein
lowest
freebind
energi
four
allel
freebind
energi
interact
peptid
mhc
ii
allel
list
tabl
also
freebind
energi
interact
peptidemhc
complex
tcr
list
tabl
vaccin
perform
antigen
compound
might
elicit
immun
respons
give
remark
degre
protect
diseas
predict
effect
epitop
mean
comput
approach
key
develop
success
vaccin
comput
epitop
predict
could
reduc
experiment
effort
need
live
cultur
fastidi
bacteria
easili
analyz
reduc
cost
also
molecular
dock
rel
new
effici
techniqu
predict
potenti
ligand
bind
site
whole
protein
target
pyogen
seriou
caus
mortal
worldwid
vaccin
pyogen
infect
immunolog
complic
goal
research
decad
surfac
protein
collabor
significantli
adhes
pyogen
host
cell
tissu
surfac
protein
respons
pathogen
mostli
antigen
henc
surfac
protein
favor
target
vaccin
design
yet
practic
human
peptidebas
vaccin
market
stem
primarili
difficulti
associ
peptid
stabil
deliveri
challeng
pose
divers
human
immunogenet
addit
peptidebas
vaccin
offer
mean
safe
immun
intervent
peptidebas
vaccin
current
develop
includ
sever
phase
iii
clinic
trial
attempt
immun
human
ga
start
mani
year
develop
vaccin
base
protein
hinder
presum
bmolecular
mimicrycaus
antibodi
rais
purifi
protein
crossreact
human
tissu
includ
heart
skelet
muscl
brain
glomerular
basement
membran
therebi
caus
concern
potenti
induct
autoimmun
far
effort
develop
practic
vaccin
pyogen
complet
success
develop
vaccin
confer
protect
infect
multipl
pyogen
type
major
challeng
vaccin
design
select
epitop
ideal
conserv
across
pathogen
variant
differ
stage
although
research
direct
toward
develop
effect
vaccin
start
mani
year
ago
commerci
vaccin
still
avail
year
revers
vaccinolog
appli
identifi
potenti
vaccin
candid
serogroup
b
meningococcu
univers
vaccin
promis
result
serogroup
b
meningococcu
identifi
besid
bacteria
approach
test
varieti
pathogen
organ
protozoan
lishmania
hiv
influenza
viru
iranian
hpv
sarscov
anoth
studi
b
cell
epitop
extracellular
domain
ecd
breast
cancer
predict
revers
vaccinolog
approach
predict
potenti
candid
done
ten
surfac
protein
staphylococcu
aureu
caus
endocard
select
epitop
simul
b
celland
cellmedi
immun
conserv
across
variou
bacteri
strain
studi
two
vaccin
candid
group
streptococcu
bacteria
compar
bioinformat
approach
research
combin
epitop
predict
bioinformat
immunoinformat
appli
howev
research
bioinformat
peptid
vaccin
continu
begin
path
previou
studi
focus
find
conserv
epitop
among
differ
protein
streptococc
bacteria
research
done
allel
manag
find
highli
conserv
epitop
among
streptococc
bacteria
exampl
epitop
aleeanskl
found
conserv
among
six
differ
type
protein
streptococc
bacteria
studi
show
possibl
find
practic
conserv
peptidebas
vaccin
streptococc
bacteria
studi
focus
detect
antigen
epitop
eight
surfac
protein
conserv
repres
among
pyogenes
strain
order
maximum
immun
respons
simul
predict
epitop
abl
simul
b
cell
cell
immun
done
prefer
promiscu
epitop
bind
affin
seven
major
histocompat
complex
mhc
allel
also
cover
major
popul
among
differ
mhc
ii
allel
focus
order
detect
cell
epitop
match
larg
hla
popul
use
epitop
predict
method
combin
molecular
dock
techniqu
predict
accuraci
greatli
improv
protect
infect
multipl
pyogen
type
one
import
feather
effect
vaccin
develop
henc
conserv
select
epitop
across
differ
strain
variant
streptococcu
type
check
studi
order
guarante
final
select
cell
epitop
appropri
candid
vaccin
design
differ
filter
appli
experiment
valid
epitop
potenti
use
requir
peptid
vaccin
pyogen
infect
fund
inform
studi
support
univers
isfahan
conflict
interest
author
declar
conflict
interest
